Document is current
Any future updates will be listed below
-
Authors
Yudina, Anastasiya
Tazearslan, Cagdas
Baisangurov, Artur
Nuzhdina, Ekaterina
Lauziere, Kelley
Segodin, Vitaly
Podsvirova, Svetlana
Starikov, Sergey
Chasse, Madison
Shaposhnikov, Kirill https://orcid.org/0009-0006-2153-8565
Kaneunyenye, Leznath
Klimchuk, Olesia
Kuzkina, Natalia
English, Noel
Khegai, Gleb https://orcid.org/0009-0003-2505-3846
Sookiasian, Danielle
Shafranskaya, Daria
Fernandez, Dawn
Lozinsky, Yaroslav
Sobolev, Andrew
Abdou, Mary
Turova, Polina
Chernyshov, Konstantin
Efremov, Alexey
Andrewes, Samuel
Feinberg, Aviva
McKenna, Brianna
Brown, Jessica H.
Love, Anna https://orcid.org/0000-0003-4627-3138
Curran, John
Lennerz, Jochen https://orcid.org/0000-0003-2434-4978
Bagaev, Alexander https://orcid.org/0000-0002-8680-854X
- License Information
-
More Information
Article History
Received: 9 March 2025
Accepted: 27 May 2025
First Online: 16 June 2025
Competing interests
: The authors declare the following competing interests: Jochen Lennerz is the Chief Scientific Officer, and Alexander Bagaev is the Chief Product Officer at BostonGene Corporation. All authors were employees of BostonGene Corporation when the study was performed. All other authors declare no competing interests.
